Collaborative Solutions
Comprehensive Medication Management
Comprehensive Medication Management (CMM) is a clinical service provided by pharmacists in various health care settings to optimize medication use and improve patient outcomes. CMM ensures that each patient’s medications are systematically evaluated to ensure they are appropriate, effective for the patient’s conditions, safe in the context of comorbidities and concurrent therapies, and feasible for the patient to use as intended. CMM involves developing an individualized care plan to achieve therapeutic goals, along with ongoing follow-up to assess real-world outcomes. This process is grounded in active patient understanding, agreement, and engagement in their care. It is increasingly supported by public and private payers in Minnesota as a strategy to improve quality and reduce avoidable costs.
Despite its growing presence, CMM implementation can sometimes vary significantly across systems in terms of frequency and duration of patient follow-up, documentation practices, and the roles of pharmacists and other care team members. Consistent evaluation frameworks are also lacking, making it difficult to compare outcomes to establish best practices.
The CMM Evaluation Project aims to understand the current state of CMM across payers, health systems, and community pharmacies in Minnesota; demonstrate what is feasible from a data standpoint to assess the delivery of CMM services; and gather baseline information to inform future patient centered outcomes evaluation.
Participants
- Blue Cross Blue Shield MN
- HealthPartners
- Hennepin Healthcare
- M Health Fairview
- Mayo Clinic
- Goodrich Pharmacy
- GuidePoint Pharmacy
- Thrifty White Pharmacy
Commercial Support Guidelines
This project is funded by Pfizer. The project will be carried out in accordance with the MNSHINE Board of Directors’ Guidelines for Engagement of Commercial Interests. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. Providers of clinical services directly to patients, and health and liability insurers, are not commercial interests – unless the provider of clinical services or insurer is owned, or controlled by, a commercial interest.
Under the guidelines, MNSHINE may seek and accept general contributions in support of mission related activities from commercial interests and may recognize entities providing these contributions in communications or at events, provided language is included outlining the guardrails established to ensure the integrity and prevent bias in MNSHINE’s work products. However, MNSHINE may not engage commercial interests or their representatives in a range of specific activities, including “participation on workgroups or technical expert panels focused on measure development, quality reporting, cost reporting, or any group where there is potential to influence policy, analysis of data, content planning, or development of materials for public reporting.” Representatives of commercial interests may, however, participate in these groups as observers.
